SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-21-041296
Filing Date
2021-12-13
Accepted
2021-12-13 06:04:59
Documents
16
Period of Report
2021-12-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K brhc10031793_8k.htm   iXBRL 8-K 63316
2 EXHIBIT 2.1 brhc10031793_ex2-1.htm EX-2.1 571768
3 EXHIBIT 99.1 brhc10031793_ex99-1.htm EX-99.1 32609
7 image00002.jpg GRAPHIC 2914
8 image00003.jpg GRAPHIC 2522
  Complete submission text file 0001140361-21-041296.txt   967323

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20211212.xsd EX-101.SCH 3929
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20211212_lab.xml EX-101.LAB 22544
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20211212_pre.xml EX-101.PRE 16046
9 EXTRACTED XBRL INSTANCE DOCUMENT brhc10031793_8k_htm.xml XML 4229
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 211486871
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences